Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1998 May;51(5):351–355. doi: 10.1136/jcp.51.5.351

Peripheral blood stem cell transplants.

J L Byrne 1, N H Russell 1
PMCID: PMC500692  PMID: 9708199

Full text

PDF
351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderlini P., Körbling M., Dale D., Gratwohl A., Schmitz N., Stroncek D., Howe C., Leitman S., Horowitz M., Gluckman E. Allogeneic blood stem cell transplantation: considerations for donors. Blood. 1997 Aug 1;90(3):903–908. [PubMed] [Google Scholar]
  2. Becker P. S., Wagle M., Matous S., Swanson R. S., Pihan G., Lowry P. A., Stewart F. M., Heard S. O. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant. 1997 Apr;3(1):45–49. [PubMed] [Google Scholar]
  3. Bird J. M., Bloxham D., Samson D., Marcus R. E., Russell N. H., Kelsey S. M., Newland A. C., Apperley J. F. Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients. Br J Haematol. 1994 Sep;88(1):110–116. doi: 10.1111/j.1365-2141.1994.tb04985.x. [DOI] [PubMed] [Google Scholar]
  4. Chopra R., McMillan A. K., Linch D. C., Yuklea S., Taghipour G., Pearce R., Patterson K. G., Goldstone A. H. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients. Blood. 1993 Mar 1;81(5):1137–1145. [PubMed] [Google Scholar]
  5. Demirer T., Buckner C. D., Gooley T., Appelbaum F. R., Rowley S., Chauncey T., Lilleby K., Storb R., Bensinger W. I. Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplant. 1996 Jun;17(6):937–941. [PubMed] [Google Scholar]
  6. Dührsen U., Villeval J. L., Boyd J., Kannourakis G., Morstyn G., Metcalf D. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood. 1988 Dec;72(6):2074–2081. [PubMed] [Google Scholar]
  7. Freedman A. S., Ritz J., Neuberg D., Anderson K. C., Rabinowe S. N., Mauch P., Takvorian T., Soiffer R., Blake K., Yeap B. Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. Blood. 1991 Jun 1;77(11):2524–2529. [PubMed] [Google Scholar]
  8. Gianni A. M., Siena S., Bregni M., Tarella C., Stern A. C., Pileri A., Bonadonna G. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet. 1989 Sep 9;2(8663):580–585. doi: 10.1016/s0140-6736(89)90711-3. [DOI] [PubMed] [Google Scholar]
  9. Gratwohl A., Hermans J., Baldomero H. Blood and marrow transplantation activity in Europe 1995. European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 1997 Mar;19(5):407–419. doi: 10.1038/sj.bmt.1700694. [DOI] [PubMed] [Google Scholar]
  10. Haas R., Möhle R., Frühauf S., Goldschmidt H., Witt B., Flentje M., Wannenmacher M., Hunstein W. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood. 1994 Jun 15;83(12):3787–3794. [PubMed] [Google Scholar]
  11. Haynes A., Hunter A., McQuaker G., Anderson S., Bienz N., Russell N. H. Engraftment characteristics of peripheral blood stem cells mobilised with cyclophosphamide and the delayed addition of G-CSF. Bone Marrow Transplant. 1995 Sep;16(3):359–363. [PubMed] [Google Scholar]
  12. Horning S. J. Treatment approaches to the low-grade lymphomas. Blood. 1994 Feb 15;83(4):881–884. [PubMed] [Google Scholar]
  13. Jones H. M., Jones S. A., Watts M. J., Khwaja A., Mills W., Fielding A., Goldstone A. H., Linch D. C. Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma. J Clin Oncol. 1994 Aug;12(8):1693–1702. doi: 10.1200/JCO.1994.12.8.1693. [DOI] [PubMed] [Google Scholar]
  14. Jones H. M., Jones S. A., Watts M. J., Khwaja A., Mills W., Fielding A., Goldstone A. H., Linch D. C. Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma. J Clin Oncol. 1994 Aug;12(8):1693–1702. doi: 10.1200/JCO.1994.12.8.1693. [DOI] [PubMed] [Google Scholar]
  15. Kessinger A., Armitage J. O., Smith D. M., Landmark J. D., Bierman P. J., Weisenburger D. D. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood. 1989 Sep;74(4):1260–1265. [PubMed] [Google Scholar]
  16. Lambrechts A. C., Hupkes P. E., Dorssers L. C., van't Veer M. B. Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non-Hodgkin's lymphoma. Blood. 1993 Oct 15;82(8):2510–2516. [PubMed] [Google Scholar]
  17. Langlands K., Craig J. I., Parker A. C., Anthony R. S. Molecular determination of minimal residual disease in peripheral blood stem cell harvests. Bone Marrow Transplant. 1990 Jan;5 (Suppl 1):64–65. [PubMed] [Google Scholar]
  18. Linch D. C., Winfield D., Goldstone A. H., Moir D., Hancock B., McMillan A., Chopra R., Milligan D., Hudson G. V. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet. 1993 Apr 24;341(8852):1051–1054. doi: 10.1016/0140-6736(93)92411-l. [DOI] [PubMed] [Google Scholar]
  19. Majolino I., Pearce R., Taghipour G., Goldstone A. H. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol. 1997 Feb;15(2):509–517. doi: 10.1200/JCO.1997.15.2.509. [DOI] [PubMed] [Google Scholar]
  20. McQuaker I. G., Haynes A. P., Anderson S., Stainer C., Owen R. G., Morgan G. J., Lumley M., Milligan D., Fletcher J., Bessell E. M. Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: a pilot study. J Clin Oncol. 1997 Jun;15(6):2288–2295. doi: 10.1200/JCO.1997.15.6.2288. [DOI] [PubMed] [Google Scholar]
  21. McQuaker I. G., Haynes A. P., Stainer C., Anderson S., Russell N. H. Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. Br J Haematol. 1997 Jul;98(1):228–233. doi: 10.1046/j.1365-2141.1997.1812998.x. [DOI] [PubMed] [Google Scholar]
  22. McQuaker I. G., Hunter A. E., Pacey S., Haynes A. P., Iqbal A., Russell N. H. Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit. J Clin Oncol. 1997 Feb;15(2):451–457. doi: 10.1200/JCO.1997.15.2.451. [DOI] [PubMed] [Google Scholar]
  23. Miflin G., Russell N. H., Hutchinson R. M., Morgan G., Potter M., Pagliuca A., Marsh J., Bell A., Milligan D., Lumley M. Allogeneic peripheral blood stem cell transplantation for haematological malignancies--an analysis of kinetics of engraftment and GVHD risk. Bone Marrow Transplant. 1997 Jan;19(1):9–13. doi: 10.1038/sj.bmt.1700603. [DOI] [PubMed] [Google Scholar]
  24. Philip T., Guglielmi C., Hagenbeek A., Somers R., Van der Lelie H., Bron D., Sonneveld P., Gisselbrecht C., Cahn J. Y., Harousseau J. L. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med. 1995 Dec 7;333(23):1540–1545. doi: 10.1056/NEJM199512073332305. [DOI] [PubMed] [Google Scholar]
  25. Russel N., Gratwohl A., Schmitz N. The place of blood stem cells in allogeneic transplantation. Br J Haematol. 1996 Jun;93(4):747–753. doi: 10.1046/j.1365-2141.1996.d01-1712.x. [DOI] [PubMed] [Google Scholar]
  26. Sheridan W. P., Begley C. G., Juttner C. A., Szer J., To L. B., Maher D., McGrath K. M., Morstyn G., Fox R. M. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet. 1992 Mar 14;339(8794):640–644. doi: 10.1016/0140-6736(92)90795-5. [DOI] [PubMed] [Google Scholar]
  27. Sierra J., Storer B., Hansen J. A., Bjerke J. W., Martin P. J., Petersdorf E. W., Appelbaum F. R., Bryant E., Chauncey T. R., Sale G. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood. 1997 Jun 1;89(11):4226–4235. [PubMed] [Google Scholar]
  28. Tricot G., Jagannath S., Vesole D., Nelson J., Tindle S., Miller L., Cheson B., Crowley J., Barlogie B. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood. 1995 Jan 15;85(2):588–596. [PubMed] [Google Scholar]
  29. Vose J. M., Anderson J. R., Kessinger A., Bierman P. J., Coccia P., Reed E. C., Gordon B., Armitage J. O. High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol. 1993 Oct;11(10):1846–1851. doi: 10.1200/JCO.1993.11.10.1846. [DOI] [PubMed] [Google Scholar]
  30. Zeng D., Dejbakhsh-Jones S., Strober S. Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplantation. Blood. 1997 Jul 1;90(1):453–463. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES